Kristin O'Berry

Title: Kristin O'Berry: Innovator in Pharmaceutical Formulations

Introduction

Kristin O'Berry is a notable inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of pharmaceutical formulations, holding a total of three patents. Her work focuses on developing innovative solutions that enhance the efficacy of pharmaceutical products.

Latest Patents

Kristin's latest patents include formulations for high concentration anti-BLyS pharmaceutical formulations. These formulations relate to a pharmaceutically active antigen binding protein, such as a monoclonal antibody. They comprise a buffering agent and a tonicity agent, which are essential for maintaining the stability and effectiveness of the active ingredient. Another patent she holds is for the BLyS antibody formulation, which shares similar characteristics and applications as her previous work.

Career Highlights

Kristin O'Berry is associated with GlaxoSmithKline Intellectual Property Management Limited, where she applies her expertise in pharmaceutical innovation. Her role involves not only the development of new formulations but also the strategic management of intellectual property related to her inventions.

Collaborations

Some of her notable coworkers include Angela Blake-Haskins and Tristan Marshall. Their collaborative efforts contribute to the advancement of pharmaceutical research and development within their organization.

Conclusion

Kristin O'Berry's contributions to pharmaceutical formulations demonstrate her commitment to innovation in the healthcare sector. Her patents reflect her expertise and dedication to improving therapeutic options for patients.